Treatment for uterine fibroid symptoms recommended by NICE

14 August 2024

iStock.com/Charday Penn

By Kaye McIntosh

Up to 30,000 women could benefit from linzagolix, a new treatment option for moderate-to-severe symptoms of uterine fibroids, guidance from the National Institute of Health and Care Excellence has recommended.

The gonadotropin-releasing hormone (GnRH) antagonist is a single tablet, taken once a day.







Log in or join for free to read more

You might also like